Sign in
4

Changes in Ownership

Jade Biosciences, Inc. Filed Acc 0001415889-23-015986

Dake Benjamin T sold 10,283 shares at $16.11 ($165,628)

  • Dake Benjamin T acquired 10,283 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Dake Benjamin T

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-06 Exercise or conversion : show line 1 in the form 10b5-1 +2,411 $1.74 $4,195 3,702 D
2023-12-06 Exercise or conversion : show line 2 in the form 10b5-1 +7,872 $2.14 $16,846 11,574 D
2023-12-06 Sale : show line 3 in the form 10b5-1 −10,283 $16.11 $165,628 1,291 D
Open-market sales · 10,283 sh · avg $16.11 · $165,628

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2023-12-06 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) −905 906 D
2023-12-06 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) −1,506 12,055 D
2023-12-06 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −1,019 16,294 D
2023-12-06 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) −6,853 123,346 D
Loading xslF345X05/form4-12072023_061201.xml…